HK1254527A1 - Pharmaceutical formulation and use thereof - Google Patents

Pharmaceutical formulation and use thereof

Info

Publication number
HK1254527A1
HK1254527A1 HK18113777.2A HK18113777A HK1254527A1 HK 1254527 A1 HK1254527 A1 HK 1254527A1 HK 18113777 A HK18113777 A HK 18113777A HK 1254527 A1 HK1254527 A1 HK 1254527A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
HK18113777.2A
Other languages
Chinese (zh)
Inventor
鄭忠立
朱文岩
Original Assignee
維爾信科技(濰坊)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 維爾信科技(濰坊)有限公司 filed Critical 維爾信科技(濰坊)有限公司
Priority to HK18113777.2A priority Critical patent/HK1254527A1/en
Publication of HK1254527A1 publication Critical patent/HK1254527A1/en

Links

HK18113777.2A 2018-10-29 2018-10-29 Pharmaceutical formulation and use thereof HK1254527A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18113777.2A HK1254527A1 (en) 2018-10-29 2018-10-29 Pharmaceutical formulation and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18113777.2A HK1254527A1 (en) 2018-10-29 2018-10-29 Pharmaceutical formulation and use thereof

Publications (1)

Publication Number Publication Date
HK1254527A1 true HK1254527A1 (en) 2019-07-19

Family

ID=71576161

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113777.2A HK1254527A1 (en) 2018-10-29 2018-10-29 Pharmaceutical formulation and use thereof

Country Status (1)

Country Link
HK (1) HK1254527A1 (en)

Similar Documents

Publication Publication Date Title
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
GB201807942D0 (en) Pharmaceutical formulation
EP3706741A4 (en) Pharmaceutical composition and use thereof
EP3434285A4 (en) Pharmaceutical composition and use thereof
IL273339A (en) Griseofulvin compound and pharmaceutical use thereof
GB201709141D0 (en) Pharmaceutical formulation
ZA202102871B (en) Pharmaceutical formulation
SG11202010124SA (en) Stable pharmaceutical formulation
IL276323A (en) 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
IL278927A (en) Pharmaceutical formulation
HK1250147A1 (en) A lyophilised pharmaceutical formulation and its use
IL279877A (en) Ivosidenib forms and pharmaceutical compositions
FI3601277T3 (en) Pharmaceutical formulation
EP3497080A4 (en) Pharmaceutical formulations and their use
EP3851108C0 (en) Borate-based drug and use thereof
EP3647325A4 (en) Pharmaceutical composition comprising pcsk-9 antibody and use thereof
EP4069233A4 (en) Pharmaceutical combination and use thereof
ZA202100166B (en) Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
IL282142A (en) 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
GB201905509D0 (en) Pharmaceutical compositions and associated lits and uses
EP3718543A4 (en) Pharmaceutical composition and use thereof
HK1254527A1 (en) Pharmaceutical formulation and use thereof
EP3763373A4 (en) Pharmaceutical formulation and use thereof
IL292646A (en) Pharmaceutical combination and use thereof